BioSpace News Archive

Combinations including Ibrutinib stood out in hard-to-treat hematological cancers at the 64th American Society of Hematology (ASH) annual meeting.

Wall Street is no longer enamored with NASH drug developers.

Genentech, a member of the Roche Group, announced interim results from the Phase III HAVEN 7 study.

Senti Biosciences, Inc., a biotechnology company innovating next-generation cell and gene therapies using its proprietary gene circuit platform, announced a presentation at the American Society of Hematology Annual Meeting in New Orleans.

Vincerx Pharma, Inc. announced a poster presentation of preclinical data of Vincerx’s proprietary payload and linker technology and VIP943, the Company’s internalizing ADC targeting CD123, at the 64th American Society of Hematology Annual Meeting 2022.

Kymera Therapeutics, Inc. presented preclinical data showing that KT-253, a novel MDM2 degrader, inhibited tumor growth as single agent and in combination with venetoclax in AML xenograft models.

Harpoon Therapeutics, Inc. presented updated interim data from its Phase 1 clinical trial evaluating single-agent HPN217 in relapsed/refractory multiple myeloma in a poster presentation at the 64th American Society of Hematology Annual Meeting and Exposition being held in person and virtually in New Orleans.

Aptose Biosciences Inc. provided a clinical update of its lead oral myeloid kinome inhibitor, tuspetinib, as responses continue to emerge from a Phase 1/2 trial, and from its oral, dual lymphoid and myeloid kinase inhibitor, luxeptinib in an ongoing Phase 1a/b trial.

Bellicum Pharmaceuticals, Inc. announced a poster presentation by the University of North Carolina Lineberger Comprehensive Cancer Center team at the 64th American Society of Hematology Annual Meeting and Exposition being held in New Orleans December 10-13, 2022.

IGM Biosciences, Inc. announced the presentation of data from IGM’s expanding portfolio of T cell engagers for hematologic malignancies, including IGM-2644, IGM-2537 and imvotamab, at the 2022 American Society of Hematology Annual Meeting and Exposition being held virtually and in-person in New Orleans, Louisiana, December 10-13, 2022.